Drug Trial News

RSS

Grape seed extract appears to lower blood pressure

Grape seed extract lowered the blood pressure of patients who participated in a UC Davis study of the benefits of the supplement on people with high blood pressure.

27 Mar 2006

Regular exercise closes the fitness gap between young and old

According to new research the older we get the harder we have to work to keep fit.

26 Mar 2006

Salvage radiation therapy for PSA recurrence following radical prostatectomy

Salvage radiation therapy to the prostatic fossa is often employed in patients with rising PSA after radical prostatectomy (RP). Interestingly, only 25% of men with rising PSA after RP have a positive prostatic fossa biopsy, yet 70% of men with a negative biopsy will have their PSA decline to undetectable levels following salvage external beam radiotherapy.

23 Mar 2006

Study investigates how age relates to survival outcome in patients with early stage breast cancer

A 30 year old woman diagnosed with breast cancer has the same chance of survival as a 60 year old woman with breast cancer according to the latest findings presented at the European Breast Cancer Conference (EBCC-5).

23 Mar 2006

Not all breast cancers' risk are increased by Hormone Replacement Therapy

Recent research presented at EBCC-5 from the million women study found that taking Hormone Replacement Therapy (HRT) increased the risk of some types of breast cancer, but not others.

23 Mar 2006

Long term reduction in LDL cholesterol dramatically reduces risk of heart disease

A new genetic analysis of more than 12,000 individuals has found that a decrease in low density lipoprotein (LDL) cholesterol, of as little as 15 percent, sustained over the long term can dramatically reduce the risk of coronary heart disease.

23 Mar 2006

Cell therapy slows progression of metachromatic leukodystrophy

In an important discovery, scientists have demonstrated that the progression of a type of genetic brain disease is slowed and symptoms are improved in mice that received cell transplants.

23 Mar 2006

Scandanavians shed new light on muscle efficiency

A recent study from Scandinavia shows that the well-known differences between individuals in the efficiency of converting energy stored in food to work done by muscles are related to muscle fibre type composition and to the content of specific molecules in muscle.

23 Mar 2006

Achieving the gold standard in breast cancer care is possible

A study in the Netherlands has proved that achieving the gold standard in breast cancer care is possible. Teams across the Netherlands set up and met targets for faster diagnosis of breast cancer and a reduction in waiting time for operations.

23 Mar 2006

Trial of paclitaxel with or without bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer

Results from a large, randomised clinical trial for patients with breast cancer show that those who received bevacizumab (Avastin.) in combination with paclitaxel (Taxol.) survived without the disease getting worse for almost twice as long as patients who received paclitaxel alone.

23 Mar 2006

Raloxifene shows potential benefits in treating prostate cancer

In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer.

23 Mar 2006

No evidence that early episodes of schizophrenia without medication result in long-term harm

A USC review of published research has found no evidence that early episodes of schizophrenia without medication result in long-term harm for patients, casting doubt on the practice to immediately medicate for a year.

23 Mar 2006

Divergent behavioral roles of angiotensin receptor intracellular signaling cascades

Researchers at the University at Buffalo and the University of Pennsylvania were the first to demonstrate that two intracellular events, both stimulated by the same cell receptor, can provoke different behaviors in mammals.

23 Mar 2006

Zinc's role in Alzheimer's disease

Zinc may be a familiar dietary supplement to millions of health-conscious people, but it remains a mystery metal to scientists who study zinc's role in Alzheimer's disease, stroke and other health problems.

23 Mar 2006

Study first to document cumulative effect of racial, sexual harrassment

New research at the University of Toronto is the first to empirically document that women who are visible minorities face a double dose of harassment in the workplace, based on both sex and ethnicity.

23 Mar 2006

Dry umbilical cord care in developing countries should be reconsidered

A topical antiseptic reduces umbilical cord infections and infant mortality risk, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health.

23 Mar 2006

Low-dose aspirin lowers potential for clot-forming blood cells - in both men and women

In what is believed to be the first direct comparison of blood cell testing in both sexes of 81 milligrams of acetyl salicylic acid a day, Hopkins researchers found aspirin therapy prevents the clumping together of these clot-forming cells, called platelets.

23 Mar 2006

Increase in Vitamin E tied to fewer in utero deaths

Manipulating the in utero environment may alter the onset of cancers that appear later in the lives of mammals, according to a new University of Toronto study published in the journal Carcinogenesis.

23 Mar 2006

Average pregnancy in the U.S. is now 39 weeks

The most common length of pregnancy in the United States is now 39 weeks, a week shorter than the traditional definition of a full-term pregnancy. This shift occurred between 1992 and 2002, according to a new analysis by the March of Dimes published this month in a special supplement of the journal "Seminars in Perinatology."

23 Mar 2006

Delayed prostate cancer intervention in low risk patients may not decrease ultimate chance for cure

A contemporary discussion exists whether patients with low-risk prostate cancer (CaP) are being overtreated with local treatment modalities. This is due to a combination of the older population affected and the slow doubling time of CaP.

23 Mar 2006